- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Congressman Frank Pallone, Jr, on Expediting the FDA Drug Approval Process
Funding from the 21st Century Cures Act to the FDA will help expedite the drug approval process without sacrificing the accountability and effectiveness of the FDA's standards, said Congressman Frank Pallone, Jr (D-NJ).
In addition to funding for the Nationa Institutes of Health, the 21st Century Cures Act grants $550 million to the FDA for research and innovation specifically for drugs and medical devices, said Congressman Frank Pallone, Jr (D-NJ).
He believes that while this initiative expedite the process for a number of programs and clinical trials, it will maintain the accountability and effectiveness of the FDA’s standards.
“I was at the European Union about a month ago talking to the equivalent of the FDA in the European Union in Brussels and we’re the gold standard,” Mr Pallone said. “We’re the most rigorous process there is for both drugs and medical devices and I think that there are ways that maybe you can streamline that without limiting effectiveness.”
Balancing Life and Myeloma: A Patient-Centered Approach
November 22nd 2024In this second part of our discussion with Don M. Benson, MD, PhD, from our recent Institute for Value-Based Medicine® event in Cleveland, Ohio, he explains how his ultimate goal for his patients is for them to live as long and as well as possible.
Read More
Community Investment, Engagement Are Essential to Fully Address Cardiovascular Health Disparities
November 19th 2024Community-based researchers can teach clinicians a lot about how to best approach underserved populations disproportionately impacted by cardiovascular health complications.
Read More
